Biotech Executives Present at Virtual Investor 'Why Now' Conference

Leaders from multiple biotechnology and pharmaceutical firms, including Ernexa, Akari, and Outlook Therapeutics, are participating in a virtual investor conference to discuss their development pipelines and market strategies. The event highlights ongoing industry efforts to attract capital amid shifting healthcare investment trends.